Position in JNJ
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$4,252,219
-$322,231 QoQ
Shares Held
16,743
-10.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#1,734
of 4,676 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Financial Alliance, LLC holds $16,023,148 across 10 Drug Manufacturers - General names. JNJ ranks #2 (26.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
17,208 | $4,330,221 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
16,743 | $4,252,219 | |
| 3 | LLY |
ELI LILLY & Co
|
1,993 | $2,390,464 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,983 | $2,053,815 | |
| 5 | AMGN |
Amgen Inc
|
2,252 | $815,494 | |
| 6 | PFE |
Pfizer Inc
|
33,547 | $807,811 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
9,222 | $531,371 | |
| 8 | AZN |
Astrazeneca PLC
|
1,540 | $292,014 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,252,219 | 16,743 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $4,574,450 | 18,714 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,873,483 | 18,717 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,472,360 | 18,727 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $2,860,243 | 18,725 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,063,728 | 18,474 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,592,602 | 17,927 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $3,001,999 | 18,524 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,734,945 | 18,712 | Shares | Sole | 2024-08-26 | |
| 2024-03-31 | $3,032,344 | 19,169 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,854,548 | 18,212 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,701,328 | 17,344 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,077,844 | 18,595 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,187,360 | 14,112 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,213,970 | 18,194 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,937,212 | 17,980 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,690,787 | 20,792 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,136,971 | 17,700 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,097,393 | 18,106 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,860,162 | 17,710 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,847,502 | 17,285 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $2,748,563 | 16,724 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,321,175 | 14,749 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,051,557 | 13,780 | Shares | Sole | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||